- £196.16bn
- £215.32bn
- $54.07bn
- 85
- 17
- 83
- 70
REG - Ophir Energy Plc - Appointment of Midstream Partner <Origin Href="QuoteRef">AZN.L</Origin> <Origin Href="QuoteRef">OPHR.L</Origin>
AnnouncementREG - AstraZeneca PLC - Notice of Results <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - MEDIMMUNE ACQUIRES DEFINIENS <Origin Href="QuoteRef">AZN.L</Origin> <Origin Href="QuoteRef">NESF.L</Origin>
AnnouncementREG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - AZ COMPLETES STRATEGIC TRANSACTION WITH ALMIRALL <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - US FDA APPROVES ONCE-DAILY XIGDUOT XR TABLETS <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Olaparib receives positive CHMP opinion <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - ASTRAZENECA UPDATES ON ONCOLOGY PIPELINE AT ESMO <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Positive CHMP Opinion for MOVENTIG (naloxegol) <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - FDA Approves MOVANTIK (naloxegol) Tablets <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - AZ AND LILLY ALLIANCE TO DEVELOP BACE INHIBITOR <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - US DOJ Closes Investigation into Plato <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - CAZ-AVI PHASE III RESULTS <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - TRALOKINUMAB PHASE III START IN SEVERE ASTHMA <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - PHASE III RESULTS LESINURAD COMBINATION THERAPY <Origin Href="QuoteRef">AZN.L</Origin>
Announcement